Earnings call transcripts

Management framed Accu-Fab as a faster, higher-margin diversification engine while conservatively planning around prolonged commercial-vehicle weakness.

Management framed the closed Parkland deal as more accretive and integration-ready, while delaying combined-company guidance until budgets and asset closings are clearer.

Management framed Q3 as the start of a simpler, delevered platform, with carbon capture operating and operational improvements supporting stronger 2026 earnings.

Management framed Q1 as a disciplined execution quarter, with near-term cell-therapy timing masking improving underlying demand and continued confidence in low-single-digit annual growth.

Management emphasized broad-based momentum, with data centers, ALM and digital solutions increasingly driving growth alongside resilient physical storage.

2025 outlook rose on broad-based momentum, while 2026 commentary introduced a new business line and higher corporate investment.

Management framed the quarter as validation of Pivot to Growth, with stronger AUSTEDO visibility and execution supporting 2027 targets.

Management framed the quarter as a strategic reset toward diabetes and obesity, with cost savings and broader access intended to restore competitiveness over time.

Management framed execution as resilient, with Illinois optimization, developing-market scaling, and Fairmont Park ramping while preserving M&A and buyback flexibility.

Management framed results around resilient leisure demand and market-share gains, while policy uncertainty, government travel declines and fixed-cost pressure constrained performance.

Management framed the quarter around accelerating electrical demand, capacity execution and a strategic expansion into liquid cooling through Boyd.

Management framed Texas legislation, lower rates and disciplined large-load execution as durable drivers above the prior growth framework.